Concepedia

Rachel Hemingway

RH

3

Publications

69

Citations

3

H-Index

2017

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Rachel Hemingway is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicinal chemistry, and toxicology.

ORCID

Top concepts

Publications per year

2017–2024

3

Publications

3

A quantitative <i>in silico</i> model for predicting skin sensitization using a nearest neighbours approach within expert‐derived structure–activity alert spaces

Steven J. Canipa, Martyn L. Chilton, Rachel Hemingway et al. · Journal of Applied Toxicology · 2017 · 35 citations

Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity

David J. Ponting, Michael J. Burns, Robert S. Foster et al. · Methods in molecular biology · 2022 · 20 citations

, , +13

<i>In Silico</i> Prediction of Pharmaceutical Degradation Pathways: A Benchmarking Study Using the Software Program Zeneth

Rachel Hemingway, Steven W. Baertschi, David Benstead et al. · Organic Process Research & Development · 2024 · 14 citations · Full text

Rows per page

1–3 of 3